Axs Vecta 71
Device catheter
PDI 07613327459210
General payments
$692,717
Research payments
$149,563
Through program year 2025, $692,717 in general payments and $149,563 in research payments were reported against Axs Vecta 71 (catheter).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $222,735 | 368 |
| 2025 | Research | $96,136 | 2 |
| 2024 | General | $157,521 | 461 |
| 2024 | Research | $44,486 | 2 |
| 2023 | General | $156,247 | 554 |
| 2023 | Research | $8,941 | 2 |
| 2022 | General | $83,080 | 235 |
| 2021 | General | $73,133 | 237 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,855 general · 6 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.